Transient ECG Changes in Patients With Acute Biliary Disease

Status Not yet recruiting

Clinical Trial Summary

Background:

The importance of ischemic ECG changes including St segment elevation, ST segment depression or T wave inversion that indicate myocardial ischemia are well established and require appropriate investigation and treatment.

However, there is an abundance of clinical situation, with apparently ischemic ECG change not indicate traditionally coronary artery related ischemia and therefore require prompt recognition and treatment of underlying condition, that may be serious and life-threatened. For example of such conditions are pericarditis, myocarditis, aortic dissection, electrolyte abnormalities, intracranial hemorrhage and hypothermia.

Together with them, an ECG ST segment changes may appeared in abdominal serious illness such as pancreatitis and cholecystitis(17,18,19,20,23). Whereas in pancreatitis various vasoactive and toxic for myocardium substances released, the cause of ST segment changes in cholecystitis are discussed and includes tachycardia , vagal reflexes, changed in plasma rennin activity resulted by distension of the gallbladder.

The certain proportion of the patients with ECG changes actually didn't have coronary artery disease(9,15) or other acute cardiac condition and therefore require treatment of the underlie illness only without spend the time for cardiac investigation or special treatment(1,3,4,7,8). Some kind of treatment may be even harmful for the patients with abdominal illness such as thrombolytic, anticoagulant, aggressive antiaggregant therapy or unnecessary cardiac catheterization.

In the medical literature the investigators found some case reports and works about the ECG changes in acute biliary disease in patient with knowing cardiac disease and without it, but actually incidence of ECG changes that suggest but not represent an acute coronary illness isn't knowing.

Therefore this is necessary to investigate actually incidence of ECG changes that mimic acute coronary syndrome in acute cholecystitis and acute biliary disease and determined clinical and laboratory characteristics that helps to differentiate this patients.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01706068
Study type	Observational
Source	Ziv Hospital
Contact
Status	Not yet recruiting
Phase	N/A
Start date	November 2012
Completion date	May 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04156711` - Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery	N/A
Recruiting	`NCT02130245` - Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study	N/A
Completed	`NCT01942356` - Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor	N/A
Completed	`NCT04995380` - Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis (SPRIMACC)
Completed	`NCT03999645` - Is it Safe to do Laparoscopic Cholecystectomy for Acute Cholecystitis up to Seven Days?	N/A
Completed	`NCT03296280` - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed	`NCT03002051` - EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent	N/A
Completed	`NCT00447304` - Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy	Phase 3
Completed	`NCT04346550` - Comparison of Morbidity After Laparoscopic Cholecystectomy for Acutely Inflamed Gall Bladder With and Without Drain	N/A
Active, not recruiting	`NCT04197908` - EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study.	N/A
Completed	`NCT02027402` - Effects of Drainage in Laparoscopic Cholecystectomy	N/A
Enrolling by invitation	`NCT04633512` - Safety and Feasibility of ActivSightTM in Human	N/A
Completed	`NCT04672902` - Treatment of Mirizzi Syndrome
Completed	`NCT03122054` - Early Versus Delayed Cholecystectomy	N/A
Recruiting	`NCT05732480` - Influence of Gut Microbiome in Gallstone Disease
Completed	`NCT04308265` - Scoring System in Acute Calculous Cholecystitis
Not yet recruiting	`NCT06287112` - Prevention of Acute Cholecystitis With ETGBD	N/A
Recruiting	`NCT05709548` - Use of Indocyanine Green in Acute Cholecystitis	Phase 4
Not yet recruiting	`NCT06459323` - the Outcomes of Laparoscopic Cholecystectomy for Acute Cholecystitis Within and Beyond the First 72 Hours, Does it Differ?!	N/A
Enrolling by invitation	`NCT06364865` - AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.